easuring pulse, heart rate, blood pressure or blood flow and combined pulse/heart-rate/blood pressure determination and evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography and heart catheters for measuring blood pressure (A61B5/02)

A   Human necessities(308424)
A61B5/02                     easuring pulse, heart rate, blood pressure or blood flow; combined pulse/heart-rate/blood pressure determination; evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography; heart catheters for measuring blood pressure(2606)

ethod for portal and/or hepatic pressure detection, and system for portal hypertension tracking // 2627154
FIELD: medicine.SUBSTANCE: devices and methods are provided that are generally related to vibration sensors for fluid external pressure measurement, namely to sensors configured to be implanted. The proposed devices and methods are particularly suitable for implantation into the body of an animal or a human to monitor physiological conditions, such as portal and/or hepatic venous pressure, and for enabling frequent venous pressure remote polling using the resonant frequency of the implanted sensor. Sensitive devices are relatively small compared to known devices for fluid pressure measurement and can be implanted into the portal-hepatic venous system, whereas the known devices are too large. The small size of the device is achieved by application of a thickened sensitive membrane as compared with the known devices, and by limiting the size of the additional elements relative to the sensitive membrane size. The more thickened sensor element also eliminates the need to use a plurality of sensor arrays and maintains high accuracy and durability of the sensing device.EFFECT: system for data acquisition, processing and display provides reading of the measured pressure and, in particular, suitable for detection of portal hypertension in patients with liver disease.63 cl, 12 dwg
Device for continuous non-invasive blood pressure measurement // 2626319
FIELD: medicine.SUBSTANCE: device for continuous non-invasive blood pressure measurement comprises an applicator (10) installed in the body (11), made in the form of a liquid-filled cavity (12) with a flexible membrane (13) to mechanically contact the patient's tissues (100) directly above the radial artery (101) and the fluid pressure transducer (14) associated with the cavity for pressure conversion to an electrical signal. The device also comprises means for membrane state regulation during measurement based on the control loop and the control unit (50) based on the microcontroller. The control loop comprises interconnected optical sensor (20) for membrane (13) positioning, fluid pressure generation unit (55), and compressor (40) communicating with the applicator cavity. The control unit (50) is connected to the computer (60) and is configured to calculate the parameters and record the blood pressure. The means for membrane (13) state regulation is adapted to maintain the initial flat state of the membrane (13) corresponding to the zero pressure difference outside and within the cavity (12), in the absence of mechanical contact of the membrane (13) with the patient's body (100). The control unit (50) is configured to predict the signal parameters of the subsequent pulse wave based on the value of the local signal period for the previous time interval calculated by the autocorrelation function (ACF) and comprises software-generated blood pressure calculation module, ACF calculation module, local period calculation module, module for prediction of the subsequent pulse wave parameters, and also unit for fluid pressure creation in the cavity.EFFECT: increased accuracy and reliability of blood pressure determination by predicting the signal of the subsequent pulse wave generated by the value of the local period determined by the autocorrelation function of signal values over the previous period of time.6 cl, 4 dwg
ethod for prediction of fetal growth retardation syndrome development at tobacco smoking background // 2626316
FIELD: medicine.SUBSTANCE: in the gestation period of 11-14 weeks, laser doppler flowmetry is used to determined one of the cutaneous microcirculation parameters, namely, the parameter characterizing the temporal variability of perfusion. According to the formula obtained by the binary logistic regression method, the prediction factor for fetal growth retardation syndrome is calculated: R=1/(1+e-z), where R is the prediction factor for fetal growth retardation syndrome; e is a constant, base of the natural logarithm equal to 2.72; z is the degree of the inverse logarithm, calculated by the formula z=b1⋅x1+a, where b1 is the regression factor, calculation of which is the task of binary logistic regression, which is equal to 5.121 in case of fetal growth retardation syndrome; x1 is the value of the independent variable, namely the parameter characterizing the temporal variability of perfusion; a is a constant equal to -4.477 in case of fetal growth retardation syndrome. At R more than 0.5, development of complications of pregnancy, namely the fetal growth retardation syndrome, is predicted.EFFECT: simplification and increased sensitivity of the method for prediction of fetal growth retardation syndrome at the tobacco smoking background.2 ex

Non-invasive method of blood rheological properties complex analysis in vivo // 2625281
FIELD: medicine.SUBSTANCE: in the zone of interest, the flow of blood through the vessel is probed with pulses of ultrasonic oscillations in the energy colour Doppler coding mode. The diameter d of the vessel, the thickness of the blood flow boundary layer, the area of the blood flow boundary layer, the area of axial blood flow, the cardiac contractions frequency are determined and parameters characterizing the blood rheological properties are calculated based on the obtained data: blood kinematic viscosityν, the Womersley number α, parameter α2, ε flow structure coefficient. The peak systolic velocity Vps of axial blood flow and the mean maximum velocity Vm of axial flow of blood are determined, the inter-intimal diameter of the vessel and the Reynolds number Re, shear rate V, and shear voltage τ are calculated based on these parameters. Intubation is carried out with a traffic intensity distribution map over the flow section and the following is further determined using the measurements: area Sos of the axial flow into the systole, area Sns of the flow into the systole, area Sod of the axial flow into the diastole, area Snd of the flow into the diastole, area Sδs into the systole, area Sδd into the diastole, systole time ts, diastole time td, heart cycle time t; and the following is calculated from the obtained data: averaged thickness δxs of the boundary layer into the systole (cm) according to the formula: δxs=Sδs/[√π*(√Sns+√Sos)], where Sδs is the area of the boundary layer into the systole, Sns is the flow area into the systole, Sos is the axial flow area into the systole; averaged thickness δxd of the boundary layer into the diastole (cm) according to the formula: δxd=Sδd/[√π*(√Snd+√Sod)], where Sδd is the boundary layer area into the diastole, Snd is the flow area into the diastole, Sod-ω is angular velocity (c-1); νs - blood kinematic viscosity into the systole (cSt) according to the formula: νs=ωδxs2; d - blood kinematic viscosity into the diastole (cSt) according to the formula: νd=ωδxd2; νh - blood hemodynamic viscosity (cSt) according to the formula: νh=[(νs x ts)+(νd x td)]/t; Σhs - coefficient of rheological effectiveness of blood flow into the systole according to the formula: Σhs=Sos/Sns, where Sos is the area of the axial flow into the systole; Sns is the area of the flow into the systole; Σhd - coefficient of rheological efficiency of blood flow into the diastole according to the formula: Σhd=Sod/Snd, where Sod is the area of the axial flow into the diastole; Snd is the flow area into the diastole; Σh - coefficient of rheological efficiency of blood flow per cardiac cycle according to the formula: Σh=[(Σhs x ts)+(Σhd x td)]/t. Erythrocytes movement characteristics are determined in the axial flow, such as motion intensity, evaluating it according to the level of colour intensity of colouring of the axial flow colour map, comparing it to the intensity level of the colour scale on the monitor screen; degree of flow disorganization according to the structure and degree of heterochromicity of the axial flow colour map, for which the axial flow structural coefficient AFSC is determined as the ratio of the area of axial flow sections with the maximum colouring intensity Sm and the axial flow area So, and at AFSC=1 flow structure is considered normally organized, and at AFSC<1 - disorganized; the erythrocyte movement intensity gradient in the direction from the vessel wall to the axial flow, estimating the degree of flow local stability by the nature of axial flow contours and boundary layer strips, the degree of axial flow cantering and the uniformity of the boundary layer thickness over the vessel section.EFFECT: improved efficiency of the analysis of blood rheological properties due to calculation of a large number of quantitative rheological characteristics of the blood flow and visual detection, which allows to localize the vessel sections with violated hemorheological parameters.13 dwg, 1 ex
ethod for predicting chronic obstructive pulmonary disease in persons with sugar diabetes of 2 type // 2625270
FIELD: medicine.SUBSTANCE: for individual predictions of exacerbations of chronic obstructive pulmonary disease (COPD) in patients with concomitant diabetes mellitus (DM) of type 2, measurements of systolic blood pressure (SBP), body mass index (BMI), a 6-minute walking test (TSW) and the COPD Assessment Test (CAT) for measuring the effect of COPD on patient quality of life. The levels are determined: glycated hemoglobin (HbA), low-density lipoprotein (LDLC) cholesterol, triglycerides (TG).EFFECT: method allows to obtain a reliable prognosis of the development of exacerbations of chronic obstructive pulmonary disease in individuals with type 2 diabetes within 1 year of observation by calculating the probability index of exacerbation of chronic obstructive pulmonary disease with the help of the original regression equation based on the data obtained.2 tbl, 2 ex

ethod of human stress diagnostics // 2624813
FIELD: medicine.SUBSTANCE: patient is recorded cardiothrit during 12 hours of daytime during his daily activity. Then, once every half an hour, a 5-minute recording interval without interference is analyzed, the standard deviation of the NN intervals (SDNN) of each of the indicated 5-minute intervals of the cardiorhythmogram is calculated. Determine by the average SDNN of 5 minute intervals the average SDNN value for every third part of the 12-hour daytime period of the day. Diagnosing chronic stress in obtaining mean SDNN values for the second and third parts of daytime, each of which differs from the mean of the preceding third of daytime of the day by less than 10 milliseconds and/or the average SDNN value for the first third of the daytime, which is less than 70 milliseconds, with an average SDNN value for the subsequent second third of daytime, equal to or less than the SDNN value for the first third of the daytime.EFFECT: method allows to provide the possibility of diagnosing chronic stress with high informativeness and reliability.4 dwg, 1 ex

Device and method for vital sign measurement of a person // 2624344
FIELD: medicine.SUBSTANCE: method for measurement of the human body state basic parameters in the illumination region, is carried out using a device for human body state main indicators measurement. At that, a visual theme near or in the area of the illumination region is provided using representation means. Lighting effects of the visual themes are subject to change in accordance with the required environment. The illumination region is lighted with light conditions to measure vital signs using the illuminating means. Optical detection of signals from the illumination area is performed by the optical measuring means. Optical detection signals are evaluated to obtain information on the vital signs from the estimated signals using the evaluation means. The control means is used for control the lighting stage in response to feedback from at least one of the stages of optical detection and assessment, to guarantee minimum lighting conditions to enable detection of signals from which the desired accuracy of information on vital signs can be obtained. The presentation stage is controlled in order to avoid changes in visual theme light effects, that (i) interfere with the rate of change of vital signs in the obtained information and (ii) reduce the accuracy of measurement information.EFFECT: improved accuracy and reliability of detection of the main human body state indicators by combining the means for visual theme presentation and measuring instrument.14 cl, 1 dwg
ethod for interactive psycho-physiological testing // 2624318
FIELD: medicine.SUBSTANCE: in the process of interactive psycho-physiological testing, questions are presented to the examinee. The physiological parameters of the examinee are recorded, and the psychological component is recorded by measuring the brain electrical conductivity using electrodes applied to the temporal areas, and directly above the ears in areas with no hair in the left and right temples 5 cm from the upper ear edges. The electrical conductivity in the temporal area and the area above ears is constantly measured during the entire time of test questions presentation. By the changes in the electrical conductivity, measured in the temporal area, an increase in the emotional stress of the examinee is judged when presenting the question. By the changes in the electrical conductivity measured above the ears, are images updating in non-volatile memory of the examinee is judged upon question presentation.EFFECT: method allows to determine the functional nature of psycho-physiological reactions when presenting the questions to the examinee, and the ability to determine whether the person recalls anything when a question is presented, or not, by conducting interactive psycho-physiological testing using electrodes applied to temporal areas and directly above the ears.9 cl, 5 dwg, 4 tbl, 3 ex

ultichannel recorder of biopotentials standard values // 2623644
FIELD: medicine.SUBSTANCE: multichannel recorder of biopotentials standard values contains N input channels, each of which includes serially connected input electrode, amplifier, low pass filter and the first input key, with the outputs of the first input keys connected to a dial-up filter input, the output of which is connected to a microcontroller via the serially connected mean square value detector and ADC; microcontroller digital output is connected to a device for information recording and display. Between the dial-up filter outputs connected to inverting inputs of the corresponding operational amplifiers of the dial-up filter and dial-up filter outputs connected to the outputs of the corresponding operational amplifiers of the dial-up filter, electrical circuits of the dial-up filter are formed, each of which consisting of N parallel branches, each of which being formed by serially connected analog key and capacitor, and between the corresponding outputs of the mean square value detector, an electrical circuit of the mean square value detector is formed consisting of N parallel branches, each of which being formed by serially connected analog key and capacitor. The first input key control input of each input channel from the first to the N-th is connected to the respective control inputs of analog keys of each parallel branch, and is connected to the corresponding first to N-th microcontroller control output.EFFECT: use of the invention allows to increase the accuracyand identity of signal registration.4 dwg
ethod for life-harmful heart rate disorders development risk prediction for children and adolescents // 2623486
FIELD: medicine.SUBSTANCE: ECG study is performed, and the cardiac electrical quality index is determined by the formula: D=(aR/aT):(QT/QRS), where D is the cardiac electrical quality index, aR and aT are the amplitude of R and T, respectively, QT is QT interval, QRS is QRS interval. With a value of D<0.55, a high risk of life-harmful heart rate disorders development in children and adolescents is predicted, with a value of 0.55≤D<0.80, a moderate risk, and with D≥0.80, a low risk of life-harmful heart rate disorders development in children and adolescents is predicted.EFFECT: method allows to predict the risk of life-harmful heart rate disorders development in children and adolescents, which will allow to develop the necessary tactics for dynamic observation of patients, and tactics for timely and adequate therapy.3 tbl, 6 ex

ethod for prediction of risk of arterial hypertension development for men of working age, working under conditions of watch in extreme north // 2623455
FIELD: medicine.SUBSTANCE: for men of working age working under the conditions of watch in the Far North, chronobiological analysis of the results of daily monitoring of arterial blood pressure is performed with subsequent determination of arterial hypertension risk after 1 year. The desynchronism of blood pressure and heart rate rhythms are considered together with the percentage contribution of the 3.4-hour rhythm of systolic blood pressure, percentage contribution of the 4-hour rhythm of diastolic blood pressure, variability of nocturnal systolic blood pressure. Using the mathematical formula, the regression equation value is calculated. Depending on the obtained value, the regression equations determine the subgroup membership of persons with low risk of arterial hypertension after 1 year or of patients with high risk of arterial hypertension development after 1 year.EFFECT: method allows to increase the accuracy of early diagnosis of arterial hypertension in persons working under conditions of watch in the Far North, by examining the dynamics of the chronobiological parameters of blood pressure rhythms.6 dwg, 2 tbl, 2 ex
ethod of diagnosis and selection of surgical treatment of patients with varicose disease of small tang // 2623331
FIELD: medicine.SUBSTANCE: patient is measured venous pressure (VP) on a segment of the left ovarian vein in length 10 centimeters. The veins are catheterized, the level of the VP No. 1 corresponding to the venous pressure in the left ovarian vein, which is the starting point of the measured pressure values, is fixed. The left ovarian vein is distal to the location of the catheterization, the level of the VP No.2 determines the retrograde pressure in the left ovarian vein, equal to the pressure in the left renal vein. The left ovarian vein is clamped proximally to the catheterization site and the central VP No.3 is determined. With VP No. 1 equal to VP No. 3 and VP No. 2, a smaller VP No.3 is assigned a resection of the ovarian vein segment. In case of VP No. 1 equal to VP No.2 and VP No.2, a larger VP No.3 is assigned a distal resection of the left ovarian vein with an anastomosis between the iliac vein and the proximal segment of the left ovarian vein.EFFECT: method allows you to determine in a timely manner the therapeutic treatment tactics.2 ex

ethod for estimation of heart tolerance to physical load and monitor // 2622614
FIELD: medicine.SUBSTANCE: patient's heart rate is continuously recorded. The value of patient's heart rate variability indicator is determined in time interval TV according to the claimed formula. Simultaneously, mechanical acceleration of patient's movements is recorded continuously using a three-component accelerometer placed near the body center of gravity. The value of the magnitude of mechanical work A spent by the patient due to his motor activity is determined in interval TA, according to the claimed formula. The value of WM index and the current value Wt of heart tolerance to physical activity are determined by the formula. For Wt≈0 a signal about reaching the limit of heart tolerance to physical exertion is generated. The wearable tolerance monitor implements the proposed method. It contains a pulse recorder, the first and the second single-channel analog-to-digital converters (ADCs), an R wave exciter, a microprocessor with random access memory (RAM), a raw data input unit, an accelerometer, a microprocessor controlled multiplexer, an acoustic indicator. At that, the pulse recorder is connected to the microprocessor via the first ADC connected in series and R wave exciter. The accelerometer is connected to the microprocessor via serially connected multiplexer and the second ADC. The raw data input unit, the acoustic indicator and the multiplexer control signal input are connected directly to the microprocessor.EFFECT: group of inventions allows to assess the heart's tolerance to physical exertion through continuous monitoring of pulse values, determination of the limit of heart tolerance to exercise and signaling its approach to the tolerance limit.1 dwg, 1 tbl

Control device and control system for hemostatic device // 2622587
FIELD: medicine.SUBSTANCE: hemostatic device is made connectable to the first compression sleeve and/or at least one second compression sleeve. Compression sleeves have different volumes. The control device has a memory. The pumping device is designed for compression sleeve pumping. The first compression sleeve corresponds to the first set of parameters including parameters for the first compression sleeve pumping process control. The second compression sleeve corresponds to the second set of parameters including parameters for the second compression sleeve pumping process control. The parameter sets are different from each other and depend on the volume of the said first and second compression sleeves. The parameter sets are stored in the control device memory. A method of hemostatic device control and a hemostatic device control system are disclosed.EFFECT: provision of rapid pumping and reliable operation of hemostatic sleeves.26 cl, 5 dwg
ethod for sanatorium treatment tactics selection for patients with arterial hypertension // 2622582
FIELD: medicine.SUBSTANCE: heart rate, daily average systolic blood pressure, average hemodynamic blood pressure and central pulse pressure are determined for with patients AH of degree 1, stages I and II. Their numerical values are established. F1, F2, F3 and F4 functions values are determined by the stated formulas. At the maximum value of F1, a course of sanatorium treatment is performed: physiotherapy, swimming, psychotherapy and sodium chloride baths balneotherapy. At the maximum value of F2 - the above sanatorium treatment complex with general magnetotherapy procedures is performed. At the maximum value of F3 - the above sanatorium treatment complex with transcerebral magnetotherapy procedures is performed. At the maximum value of F4 - the above sanatorium treatment complex with general and transcerebral magnetotherapy procedures is performed.EFFECT: possibility of individual selection of sanatorium treatment tactics for patients with AH of degree 1, stages I and II, increased efficiency of treatment due to evaluation of the most significant indicators of central hemodynamics and blood pressure.1 tbl, 4 ex

Determination of characteristics of object flow moved in element // 2622447
FIELD: medicine.SUBSTANCE: device comprises a light emitting unit configured to emit light in the element direction, a light detection unit, arranged to capture light scattered back to the element, an optical unit adapted to spatial separation of the light incidence portion of the element from the portion of the light detection element. The optical unit comprises a light path separation element which is adapted to divide the emitted light path and the backscattered path, and a determination unit configured to determine the flow characteristics of the object based on light indicating the emitted light and the detected backscattered light. The method is carried out by means of the device.EFFECT: use of inventions allows to increase the sensitivity of measurement by improving the signal-to noise ratio.13 cl, 4 dwg
ethod for biological age determination for humans or animals // 2622184
FIELD: medicine.SUBSTANCE: heart weight relative to the body weight is determined in %, together with heart rate, oxygen content in the lungs alveolar air in %, average life expectancy in the region of living for the given time period (Dstatistical), actual age (Df). Entropy is calculated in %. If the individual is a human, the average life expectancy (Do average) is determined according to number 5.262 multiplied by the inverse entropy value and addition of the number of years, obtained by subtraction of 31.3 years for men and 33.3 years for women from Dstatistical, to the obtained value. If the individual is an animal, the average life expectancy (Do average) is determined according to number 5.262 multiplied by the inverse entropy value. Next, the biological age is determine by the stated formula.EFFECT: group of inventions alows to determine the biological age of humans and animals due to entropy determination.2 cl, 7 ex

Signal detection with reduced distortion // 2620571
FIELD: physics.SUBSTANCE: device contains: interface for receiving the data stream received from the electromagnetic radiation reflected by an object, a converting means to transfer the characteristic signal to the portable signal, wherein each of, at least, two differential components can be obtained through the appropriate arithmetic conversion containing partial subtraction of one of the three absolute components of the remaining absolute components, wherein the arithmetic conversion additionally contains the coefficients for each of the two differential components, that partly have an amount essentially equal to zero, and wherein the two differential components provide the possibility of partial suppression of the clutter signal part in the portable signal; and an extracting means for extracting the partially periodic vital signal of the two differential components in the portable signal.EFFECT: improving accuracy of obtaining the object vital signals.14 cl, 14 dwg

Guide sensor conductor // 2620305
FIELD: medicine.SUBSTANCE: guide sensor conductor for intravascular measurements of physiological variables in a living body or of external signals has a proximal, distal and end regions. The longitudinal axis of the conductor core is parallel to the longitudinal axis of the guide sensor conductor. The sensor element of the guide conductor is located in the distal region of the sensor and has a sensitive portion to measure a physiological parameter or an external signal. The sensor element has a flat main surface and a maximum length in the mane surface plane, and thickness perpendicular to the main surface plane. The sensor element is located perpendicularly to the core against the flat main surface that contains the sensitive portion. The sensor element is equipped with a through passage in the perpendicular direction with respect to the main surface and is mounted relative to the core so that the core extends through this passage. The plane of the sensor element is perpendicular to the core longitudinal axis.EFFECT: increased flexibility and improved bending profile of the guide sensor conductor distal portion to ensure high measurement accuracy.17 cl, 15 dwg
ethod of diagnosing critical fetus condition // 2620005
FIELD: medicine.SUBSTANCE: remote cardio-feto monitoring is carried out for 10-30 minutes using fetus doppler in pregnant women, starting from 26 weeks, in the sitting position. Fetal heart rate, posteriori entropy of the fetal heart rate and short-term heart rate variability (STV) are determined according to Redman. Fetus condition coefficient P is calculated based on the resulting data according to the formula. If values of fetus condition coefficient P are less than 500, the critical fetus condition is diagnosed.EFFECT: method enables to improve the accuracy and reliability of the diagnosis.3 ex
ethod for infrared evaluation of human resistance to blood loss // 2619789
FIELD: medicine.SUBSTANCE: longest finger of the hand is preliminarily determined. After 30 minutes, when the examined subject is located in the room at a temperature of 25°C with bare hands, the shoulder of the other arm is circularly compressed with a tonometer cuff under pressure, which ensures veins compression. At that, the examined person is suggested to begin to delay breathing for the maximum possible period of time, causing the maximum possible apnea. Using a thermal imager in the range of +24 - (+25)°C dynamics of the local temperature in the center of the bare cushion of the previously selected longest finger is recorded before, during and 3 minutes after compression of the other arm shoulder, and the moment of holding the breath, also recording the duration of apnea. Then, compression of the other arm shoulder with the tonometer cuff is stopped, the difference in the local temperature in the center of the finger cushion under examination and the duration of the apnea is determined, and the resolution is provided. If local temperature reduction of more than 1.0°C and apnea duration of more than 50 seconds are recorded, a conclusion is made about high human resistance to blood loss. If local temperature reduction less than 0.5°C and apnea duration of less than 39 seconds, a conclusion is made about low resistance to blood loss.EFFECT: method ensures safety and accuracy of assessment of human resistance to blood loss, as well as the possibility of selection of the individuals adapted to blood loss, preserving consciousness and performance after blood loss.1 ex
Prediction method of intestinal failure development in patients with gastrointestinal bleeding // 2618925
FIELD: medicine.SUBSTANCE: in order to predict intestinal failure development in patients with gastrointestinal bleeding, blood pressure is measured since the appearance of gastrointestinal bleeding clinical signs. When a systolic blood pressure value is lower than 70 mmHg, lasting for more than 80 minutes, intestinal failture has a high development probability.EFFECT: method enables to predict intestinal failure development in patients with gastrointestinal bleeding to provide early preventive treatment.3 ex, 1 tbl
ethod for biological age determination for women // 2617801
FIELD: medicine.SUBSTANCE: clinical and functional indices are measured: hearing acuity, vital capacity, accommodation, subjective health assessment, time of statistical balancing on one leg, arterial systolic, diastolic and pulse pressure, expiratory breath hold, body weight, R-R electrocardiographic interval. Regression analysis is performed based on "derivative indicators". The biological age is calculated by the stated formula.EFFECT: method allows to accurately determine the biological age, to estimate the rate of aging and woman's health due to comprehensive assessment of the most significant indicators.4 ex
ethod for biological age determination for men // 2617313
FIELD: medicine.SUBSTANCE: clinical and functional indices are measured: hearing acuity, accommodation, vital capacity, arterial systolic, diastolic and pulse pressure, arterial systolic, diastolic and pulse pressure, statistical balancing on one leg, symbol-to-digital Wechsler attention test, body weight, subjective health assessment, Q-T electrocardiographic interval. Regression analysis is performed based on "derivative indicators". The biological age is calculated by the stated formula.EFFECT: method allows to accurately determine the biological age, to estimate the rate of aging due to comprehensive assessment of the most significant indicators.6 ex

Device and method for evaluation of heart rate while moving // 2616764
FIELD: medicine.SUBSTANCE: inventions refer to medicine. The method for determination of human heart rate is implemented by means of a portable device, which is part of the system to determine the heart rate. The portable device for human heart rate determination contains a heart rate measuring unit for generating a of heart rate signal, a movement measuring unit for measurement of human body parts movement to generate a motion signal, and a processing unit for heart rate signal frequency quality, heart rate calculation based on the heart rate signal if the signal quality is above the predetermined threshold, and evaluation of heart rate based on the motion signal, if the signal quality is below the said threshold. The processing unit evaluates the heart rate signal based on the motion signal by estimating a constant heart rate HRconstant and determining the exponential changes in heart rate over time. The exponential change in heart rate starts from the last valid measured heart rate and ends at an estimated frequency of HRconstant, which depends on the motion signal frequency. The last reliably measured heart rate value is the last heart rate measured by the heart rate measuring unit at the time before reaching the said threshold.EFFECT: invention provides increased accuracy of heart rate determination.13 cl, 12 dwg

ethod and system for control of biometric data // 2616540
FIELD: biotechnology.SUBSTANCE: invention relates to control of biometric data. Control method of biometric data, comprising steps of: user is authenticated; content is provided to user device, associated with user; biometric data is obtained associated with user; biometric data is compared with one or more limit values; generating one or more sets of data based on comparison step; suitable content is selected for user based on comparison step; and selected suitable content is provided to user.EFFECT: technical result is enabling user access to content taking into account passive periodic monitoring of biometric user data.18 cl, 6 dwg
ethod for dental-maxilla apparatus muscular component functional state assessment // 2616179
FIELD: medicine.SUBSTANCE: laser Doppler flowmetry (LDF) is used to measure the microcirculation indices before and after tooth silicone capacitor administration for 20 minutes. LDF-gram is recorded, and neurogenic and myogenic tone performance is compared. If the re-study results comply with the physiological norm, maintained rehabilitation potential is diagnosed, in case of partial normalization, reduced rehabilitation potential is diagnosed, and if any positive dynamics is absent, sharply reduced rehabilitation potential is diagnosed.EFFECT: method allows to increase diagnosis accuracy due to recording and analyzing of myogenic and neurogenic tone performance to identify functional muscle reserve.2 cl, 6 dwg

Direct deployment system and method // 2616131
FIELD: medical equipment.SUBSTANCE: group of inventions relates to medical equipment, namely to system and method for direct deployment and implantation of a device to monitor physiological conditions e.g., of the body including, for example, the pressures inside the portal and hepatic veins. Deployment system for deploying an implantable device, comprising a cannula a pushrod, a controlled deployment mechanism, and said implantable device. Implantable device is attached to the controlled deployment mechanism with a possibility of detachment. Pushrod, the controlled deployment mechanism and said implantable device are contained within the cannula Controlled deployment mechanism has a negative force limit and is located at the distal end of the pushrod, and it is made with a possibility of controllable detachment of implantable device when the negative force limit is achieved - during the backdriving of pushrod. Method of deployment the implantable device into the target location using the above system of deployment includes the steps according to which the system is advanced to the target location apply an adjustable amount of force release of the implantable device from a controlled deployment mechanism, thus securing the implantable device in the target location and removing the pushrod and a cannula. In the second option method of deployment the implantable device into the target location using the above system of deployment includes the steps according to which the system is advanced to the target location apply amount of force to secure the implantable device at the target location, apply amount of force to provide reliable fixation of the implantable device, detach the implantable device out of the controlled deployment mechanism and remove the pushrod and a cannula.EFFECT: use of the invention allows to provide safer access thanks to a smaller diameter of punctures, additional spaces for implantation, reduced procedure time and increased availability of implantation spaces.41 cl, 12 dwg

ethod for determination of athlete cardiorespiratory system state compliance with selected sport // 2615872
FIELD: medicine.SUBSTANCE: minute respiratory volume is measured in the initial state and at the end of functional exertion with increasing inhalation hypercapnia at carbon dioxide content of 7.5 vol % in the inhaled air. Heart rate is measured n the initial state and at the end of functional exertion with increasing inhalation hypoxia at oxygen content of 11 vol % in the inhaled air. Chemoreactivity fitness index (CFI) of the cardiorespiratory system is calculated by the original formula. If the value of CFI is less than or equal to 40%, the conclusion is made on cardiorespiratory system state compliance with the sport types related to cyclical aerobic muscle activity, accompanied by willed breath delays. If the value of CIF is in the range of 40 to 60% inclusive, the conclusion is made on cardiorespiratory system state compliance with the sport types related to cyclical aerobic muscle activity without willed breath delays. If the value of CFI exceeds 60%, the conclusion is made on cardiorespiratory system state compliance with the sport types related to acyclical aerobic muscle activity with abrupt changes of power or speed load. If the CFI value of an athlete does not correspond to the muscle activity typical for the sport, he/she is engaged with, a conclusion is made on cardiorespiratory system state non-compliance with the selected sport type, it is recommended to select another sport type with CFI value closer to the individual CFI of this athlete.EFFECT: method allows to determine the cardiorespiratory system state for sport types, detect non-compliance of the cardiorespiratory system state to the selected sport and to recommend the most suitable sport.4 cl, 1 dwg, 1 tbl, 3 ex
ethod for evaluation of bisoprolol treatment effeciency for patients after myocardial infarction in presence of sinus rhythm // 2615730
FIELD: medicine.SUBSTANCE: for patients, aged from 46 to 55 years, heart rate is determined, SBP is measured and vagosympathetic balance is determined by LF/HF calculation according to the original formula. At LF/HF≤1, bisoprolol treatment is considered optimal and no correction is performed. If the calculated ratio is LF/HF≥2, the bisoprolol dose is changed or another selective beta-blocker is used. for atients aged 56 years and older, heart rate is determined, SBP is measured and sympathetic manifestations probability is calculated according to the A.M. Wayne table, vagosympathetic balance is determined by LF/HF calculation by the formula. At LF/HF≤1, bisoprolol treatment is considered optimal and no correction is performed. If the calculated ratio is LF/HF≥2, the bisoprolol dose is changed or another selective beta-blocker is used.EFFECT: group of inventions allows to evaluate the bisoprolol treatment effeciciency for patients after myocardial infarction.4 cl, 1 ex, 1 tbl

Device for eustachian tube diseases research and treatment // 2615273
FIELD: medicine.SUBSTANCE: device consists of a flexible guide catheter with metric markings on the outer surface and a tapered front portion. The catheter is installed in a semicircular metal trough with a bend. A truncated cone bushing is rigidly connected to the rear part of the trough. An elliptical ring is rigidly fixed to the outer surface of the bushing. The catheter is fixed to the groove by bushings. An adapter is installed to the rear part of the catheter for endoscope connection.EFFECT: safety of optical inspection of the eustachian tube and a possibility of treatment of eustachian tube patency disorders.1 dwg
ethod for pilot occupational health diagnosis // 2614939
FIELD: medicine.SUBSTANCE: pilot undergoes an examination in the course of which, based on the medical-flight commission advice, according to the measured height and weight parameters, blood pressure, heart rate, "SUN", "Cuba", "Black and red table" test execution, modified Ruffier test, Stange's test, filling out of the "Motivational questionnaire "Service Factors Assessment", determination of the total score for physical training, body face-up retention time, body face-down retention time and half-squat position retention time, private scores are assigned. According to the obtained private scores, the occupational health score (OH) is calculated based on the mathematical formula. Depending on the OH value, the pilot referred to as belonging to "healthy", "almost healthy", "weak" or "premorbid state" group.EFFECT: method allows to increase the determination accuracy for the complex assessment of pilot's individual occupational health status of by considering complex informative characteristics of his clinical status, functional stability and professionally important qualities during the diagnosis of pilot's occupational health.5 tbl, 2 ex
ethod for blood pressure monitoring // 2613780
FIELD: medicine.SUBSTANCE: blood pressure (BP) is measured at all four limbs consecutively clockwise in the lying position. The mean dynamic blood pressure (MDBP) is determined by the Hickam formula. If MDBP is beyond 79.5115.5÷ mmHg at one or more limbs, the time interval set between each successive measurements of blood pressure at all four limbs. With MDBP normalization at all four limbs, blood pressure is measured sequentially at a predetermined time interval at each of the four limbs.EFFECT: method allows to identify early violations of arterial blood flow, thereby increasing the interval between blood pressure measurements at one limb, which reduces discomfort for the patient.4 ex
ethod of intraoperative hypotension prediction during anesthesia // 2613564
FIELD: medicine, pharmacy.SUBSTANCE: invention refers to medicine, namely to anesthesiology. For general anesthesia, 500 mg/kg of esmosol is injected for 1 minute intravenously as a medication. During assessment of the central hemodynamics response, patient's heart rate, mean arterial pressure and left ventricular power index are determined. If the heart rate is 50-100 per minute, both before and after drug administration, mean arterial pressure is 65-135 mmHg both before and after drug administration, and the value of the left ventricular power index after administration of the said formulation reduces by 27% and more compared to the value obtained before administration, intraoperative hypotension, which consists in mean arterial pressure decrease below 60 mm Hg is predicted.EFFECT: invention allows to predict intraoperative hypotension during general anesthesia.2 cl, 2 tbl, 1 dwg, 2 ex
Device for long-term remote invasive monitoring of state and critical changes of cardiovascular system for patients with comorbidity // 2613086
FIELD: medicine.SUBSTANCE: invention refers to medical equipment. The device for long-term remote invasive monitoring of state and critical changes in the cardiovascular system for patients with comorbidities comprises an implantable pressure sensor equipped with a wireless charger. The pressure sensor is configured to be mounted outside the vessel by a cuff. A wireless data transmitter is located in the electronics unit arranged in a sealed housing with the possibility of location outside the container, and connected to the sensor via a conductor. The pressure sensor is a MEMS sensor configured to monitor blood pressure, as well as for monitoring for status and critical changes in the cardiovascular system for patients with comorbidities for a predetermined period of time.EFFECT: invention provides wireless connection to power supply for the pressure sensor.3 cl, 3 dwg
ethod for human biological age determination based on morphofunctional parameter combination determining health assets // 2612602
FIELD: medicine.SUBSTANCE: invention can be used to determine the biological age of a person, his/her health assets, quantitative assessment of health-training and rehabilitation programs efficiency in the practice of exercise medical monitoring, improving physical training and physical therapy in order to assess the efficiency of rehabilitation processes and rejuvenation. Health status, bad habits and cardiovascular and respiratory systems functional state indicators, muscle strength, physical performance and psycho-emotional state of a person are analyzed. The most informative indicators are detected and the degree of their deviation from the age norm are determined as a score.EFFECT: method allows to determine biological age by taking into account informative morphological and functional indicators.6 tbl, 5 ex
ethod for diagnostics of ventricular arrhythmia, conditioned by psychoemotional factors, in patients without structural heart pathology // 2611948
FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to cardiology, and can be used for diagnostics of ventricular arrhythmia (VA), conditioned by psychoemotional factors. For patients without structural heart pathology mental tests are performed: mental Stroop test, return of anger, arithmetic count, talk about illness with simultaneous ECG registration. If reaction to at least one test is present in form of appearance of disappearance of arrhythmia, twofold and higher increase or decrease of ventricular ectopic complexes, ventricular arrhythmia, conditioned by psychoemotional factors, is diagnosed.EFFECT: method makes it possible to determine connection of VA with psychoemotional factors and diagnose VA without structural heart pathology due to applications of psychological methods with ECG.3 tbl, 6 ex
ethod for early diagnostics and prediction of diabetic and hypertensive retinopathy progressing in case of combined course of type 2 diabetes mellitus and hypertensive disease // 2610535
FIELD: medicine.SUBSTANCE: invention relates to early diagnostics of retinopathy (DR) in patients with combined course of type 2 diabetes mellitus (Type 2 DM) and hypertensiove disease (HD). Optic coherent tomography (OCT) of macular zone (MZ) of retina is performed, volume of retina thickness in 9 sectors: in fovea centralis, 3 and 5 cm from it from nasal, temporal upper and lower sides is determined. After that, change of sensitivity threshold of MZ is determined by method of fundus-microperimetry MAIA by demonstrating light stimuli into the area of fovea centralis and 3 and 5 cm around it. Level of glycated haemoglobin in patient's blood plasma is determined by standard method, prekallikrein and kallikrein level indices, as well as activity of elastase from neutrophils (NE) in lacrimal fluid (LF) samples are determined by photometric method with application of chromogenic substrates. Patient's systolic and diastolic arterial pressure (SAP and DAP) are measured. The following criteria are calculated on the basis of obtained data by mathematical calculations: R1, characterising expression of increase in edema volume thickness by thickness of retina in the said 9 MZ sectors; R2, characterising degree of change of MZ sensitivity threshold taking into account light stimulus intensity; D3, characterising the level of glycated haemoglobin (HbA1c) in blood plasma; D4, characterising the level of perkallikrein in LF; D5, characterising the level of kallikrein in LF; D6, characterising the level of NE in LF; D7, characterising the level of SAP; D8, characterising the level of DAP. After that, value of DRDH criterion is calculated by formula , where R1, R2, D3, D4, D5, D6, D7, D8 are the values mentioned above. Group and risk of disease progressing are determined in accordance with generalised DRDH criterion in accordance with the following intervals: at 1.75≥DRDH>1.72 - preclinical stage of DR; at 1.72≥DRDH>1.67 - non-proliferative stage of DR, low risk of progressing; at 1.67≥DRDH>1.63 - non-proliferative stage of DR, high risk of progressing with unfavourable clinical prediction for vision.EFFECT: method provides prediction of possibility of retinopathy progressing taking into account compensatory-adaptive consistency of vascular system in patients of the said group and early diagnostics of preclinical stage of the said pathology.15 dwg, 2 ex
ethod of long-term individual control of arterial pressure and pulse // 2607792
FIELD: medicine.SUBSTANCE: invention refers to medicine, biorhythmology. Method of long-term self-control of arterial pressure and pulse involves measuring of AP and pulse every hour in 5 replications every 2 minutes for 10 minutes: 1st measurement is carried out immediately after tonometer switching on, 2nd – at 2 minute, 3d – at 4 minute, 4th – at 6 minute, 5th – at 8 minute during 16 hours: from 7.45 to 23. During measuring it is necessary to take into account biological rhythms – measurement is performed, when the Moon at passes the same constellation annually in same months twice – in winter and summer, in same or neighboring lunar day. Measurement is made accurately 15 minutes before end of every hour. From obtained data average daily values of AP and pulse are calculated, plot dependence of SISav – age (year) and PULav – age (year) are drawn.EFFECT: method allows any adult during whole life to perform long-term individual control of arterial pressure and pulse and timely respond to their change.1 cl, 6 ex, 6 tbl, 6 dwg
ethod of assessing tolerance to kinesitherapy in patients with acute cerebral failure // 2607161
FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to rehabilitology, and can be used for evaluation of tolerance to kinesitherapy in patients with acute cerebral insufficiency. Bicycle power sampling is made. Arterial pressure (AP) and heart rate (HR) are controlled. Cardiac index (CI), total peripheral vascular resistance (TPVR), oxygen consumption (C02) and actual power consumption (PC) are also measured. These indices are defined immediately before bicycle power sampling and after 5-minute active loads of various intensity. Value of maximum active load is determined, which causes no developing of adverse reactions and complications, if two or more of measured values vary by more than 30 % from initial values.EFFECT: method enables simple, accurate and complex evaluation of tolerance to kinesitherapy in patients by taking into account most significant parameters.1 cl, 2 tbl, 2 ex

ethod of biathlete heart rate ejecting force damping during shooting in prone position // 2606872
FIELD: sports.SUBSTANCE: invention relates to high performance sport, namely, to biathlon. Invention aims at determination of skier harmonic component W0 frequency subject to damping at increased heart rate (160–190 bpm). Set task is solved by heart rate ejecting force spectral analysis using additional weight, as a result of which, harmonic component W0 frequency is determined by heart rate ejecting force Fn maximum value. Damping of said harmonic component is provided by installation of resilient armrests under elbow joints bends, each with own natural oscillation frequency Warmrest. Due to installation of resilient armrests under elbow joints bends, calculated individually, for each athlete, biathlete heart rate ejecting force is dumped so, that it becomes minimal and does not affect final result of shooting.EFFECT: disclosed method allows significantly reduce heart rate effect on shooting in prone position under conditions of competitions.1 cl, 2 tbl, 2 dwg

Fever detection apparatus // 2602676
FIELD: medical equipment.SUBSTANCE: group of inventions refers to medical equipment, namely to a fever detection apparatus. Device comprises a unit for providing a heart rate value, unit providing a peripheral physiological value, unit for determining heart rate characteristics from the heart rate value, unit for determining peripheral characteristics from the peripheral physiological value, fever detection unit for detecting fever depending on the heart rate characteristics and the peripheral characteristics. Method is implemented by the apparatus operation. Computer readable carrier contains program code means for causing a fever detection apparatus to carry out the steps of the fever detection method.EFFECT: use of inventions group allows to improve reliability of fever detection.16 cl, 4 dwg

Device and method for measuring human arterial pressure value // 2601697
FIELD: medicine.SUBSTANCE: invention relates to medicine. Arterial pressure measuring device for human contains unit for measuring arterial pressure value, comprising pressure sensor, unit for recording deviations of arterial pressure value, equipped with optical sensor, controller, and display. Unit for measuring arterial pressure value and unit for recording deviations of arterial pressure value are combined into wrist measuring capsule. Device comprises elastic membrane, with connected thereto wrist measuring capsule. Wrist measuring capsule or controller comprises small-size air or hydraulic pump. Method for measuring arterial pressure value in human is implemented by means of device for measuring arterial pressure value, that is located on wrist of person. At that performed continuous recording of deviations of arterial pressure value from initial value, displaying excess from allowed deviation, and simultaneous accurate measurement of arterial pressure value.EFFECT: higher efficiency is achieved of measuring arterial pressure due to expansion of functional capabilities of device with simultaneous improvement of mobility, reliability, and convenience of use, as well as accurate transmission of pulsations from radial artery to pressure sensor, and effective delivery of required air volume into wrist measuring capsule, thus providing required pressure force in order to increase accuracy of measurements.9 cl, 7 dwg

Device for measuring skin blood flow // 2599371
FIELD: medicine.SUBSTANCE: invention refers to medical equipment and is intended for measuring skin blood flow on the basis of the method of laser Doppler flowmetry. Device comprises primary source of laser radiation, primary radiation transportation system, secondary radiation receiving system and two channels of the signal electronic processing. Primary radiation transportation system comprises two optical fibers and a model simulating the optical properties of living biological tissue without blood. Secondary radiation receiving system comprises two optical fibers. Circuit of each channel comprises serially connected photodetector, filter of high frequencies, amplifier and an analog divider. Signal processing circuit on each channel additionally includes a low pass filter with a cutoff frequency of 2 Hz, connected in parallel with the photodetector and the second input of analog divider. Device also includes a differential amplifier, inputs of which are connected to analog outputs of the two channels dividers, and the output - with the scheme for calculating the index of perfusion.EFFECT: improved accuracy of received frequency microcirculation rhythms is achieved due to a removal from signal of spurious spectra in differential stage and elimination of subtraction of in-phase correlated useful signals at differential amplifier.1 cl, 7 dwg

Detection and monitoring of abdominal aortic aneurysm // 2597774
FIELD: medical equipment.SUBSTANCE: group of inventions relates to medical equipment. Device for testing a subject for detecting a state of a vascular pathology of the subject, comprising sensor designed to take up signal representing pulsation in an amount of blood in a subject's body, a unit of signal of the sensor to receive the sensor signal. Signal of the sensor has a DC component. Comparator compares the signal of the sensor with a reference signal. Reference signal is the signal of sensor obtained in earlier moment in time when testing a subject. Increasing value of DC component in a signal of the sensor indicates that the aneurysm grows. User interface transmits result based on comparison of the reference signal and direct current component to the user of device. Method of testing subject to assess the progress of the condition of aortic aneurysm is disclosed.EFFECT: invention provides increase of accuracy of non-invasive studies to determine vascular pathology.6 cl, 6 dwg
ethod for determining volume rate of regional blood flow for carrying out selective antegrade perfusion // 2596059
FIELD: medicine.SUBSTANCE: before starting artificial blood circulation main arteries of the organs, selective antegrade perfusion of which will be required in the process of operation, are exposed After that, volume rate of blood flow is measured by means of Doppler flowmetry in each of exposed main arteries Pre-prepared separate main of artificial blood circulation apparatus is connected to main artery of the organ, selective antegrate perfusion of which is performed during operation After that, blood supply by main of artificial blood circulation apparatus into main artery, connected to it, is realised at the volume rate, which was measured in said main artery before starting artificial blood circulation.EFFECT: method makes it possible to avoid both hypoperfusion and hyperperfusion due to taking into account factors, characteristic of particular patient.

ethod and device for positioning in doppler ultrasonic transducer for measuring blood flow and system for measuring blood flow // 2595475
FIELD: medical equipment.SUBSTANCE: group of inventions refers to medical equipment, namely to devices for positioning Doppler ultrasonic transducer. Method comprises steps of detecting signal of pressure fluctuations of blown with cuffs located on an artery of a patient, an ultrasonic pulse signal from Doppler ultrasound converter located along the artery, first signal is removed from the signal of pressure fluctuations and ultrasonic pulse signal, wherein the first signal indicates the degree of synchronisation between the signal of pressure fluctuations and ultrasonic pulse signal, and output signal indication to indicate that Doppler ultrasound transducer is in the required position, when the first signal meets a predetermined condition. Method is implemented by device comprising a first detector for detecting signal of pressure fluctuations of blown with a cuff, a second detector for detecting ultrasonic pulse signal from Doppler ultrasound converter located along the artery, a processor and interface. Blood flow measurement system comprises a cuff, Doppler ultrasound transducer arranged along the artery, and positioning device Doppler ultrasonic transducer.EFFECT: using the inventions enables increasing accuracy of positioning.15 cl, 4 dwg

ethod for integrated treatment of chronic bacterial recurrent cystitis in females at aggravation stage // 2593889
FIELD: medicine. SUBSTANCE: invention can be applied to integrated treatment for cystitis in females in exacerbation condition. Time-keeping is performed daily, which involves determining maximum peak of patient's psychic, emotional, and physiological activity. At detected individually for each patient time, exposure is made that covers bladder projection with low-intensity discrete modulated red light. Wavelength =650-680 nm, modulation frequency = 76 Hz, pulse to pause rate 4.3 units, power density 25-30 W/cm2. Exposure duration is 5 minutes. Therapeutic course 6 to 10 days. EFFECT: method allows increasing efficiency and reducing treatment length in chronic bacterial cystitis due to accurate determination of procedure time, which provides faster tissue regeneration, reduction of pain syndrome, relieving oedema and inflammation, improved blood circulation, and higher body resistance against disease. 4 cl, 4 dwg, 3 ex

ethod for prediction of multiple organ failure // 2593043
FIELD: medicine. SUBSTANCE: invention relates to medicine, specifically to anaesthesiology and resuscitation. Method includes measuring, in a patient in a prone position with head end lifted by 30°, blood pressure on four limbs according to Korotkoff method. Values of average dynamic blood pressure (ADsr.) are measured, wherein blood pressure is calculated by formula ADsr. = ADdiagnostic + ADpulse/3. If value ADsr. is less than 79.5 mm Hg. or higher than 115.5 mm Hg at three and more extremities, development of multiple organ failure is predicted. EFFECT: method simplifies and cuts duration of patient examination. 1 cl, 3 tbl, 4 ex

ethod for prediction of physical rehabilitation of patients with arterial hypertension // 2592249
FIELD: medicine. SUBSTANCE: invention refers to medicine, particularly cardiology, and can be used for prediction of effectiveness of rehabilitation actions in patients with arterial hypertension. By heart rhythm variability (HRV) during execution of active orthostatic test in patients, at which patient is in initial horizontal position for 4-6 minutes, then passes into vertical position and is in for 3 minutes. Obtained data are processed by automated diagnostic system to determine voltage regulatory systems at 12-point scale. Reaction is assessed on ortho-sample at 5-point scale. At tension of regulatory systems at level of 10-12 points in initial horizontal position, at level of reaction to ortho-sample 1 or 4 points in period of transition to vertical position positive effect of physical rehabilitation is predicted. EFFECT: method allows applying individual rehabilitation programs considering possible risk ability, as well as predicting effectiveness of physical rehabilitation ensured by determining change pattern of adaptation level in patients with arterial hypertension. 1 cl, 2 dwg, 3 ex
 
2550906.
Up!